TabletsClinical Overview
Drotaverine Hydrochloride (80mg) and Aceclofenac (100mg) Tablets combines a selective phosphodiesterase-4 (PDE4) inhibitor smooth muscle relaxant with a COX-2 preferential NSAID. Drotaverine elevates cyclic AMP in visceral smooth muscle to abolish spastic contractions, while aceclofenac inhibits prostaglandin synthesis, eliminating inflammation and pain. Indicated for severe spasmodic dysmenorrhea, biliary colic, renal/ureteric colic, and spasmodic abdominal pain.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Take orally 1 tablet twice daily with food or milk with a glass of water. Swallow whole.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Nausea, epigastric distress, dizziness, headache, dry mouth, mild hypotension. Rare/Severe: Peptic ulceration, gastrointestinal hemorrhage, and transaminase elevations.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Contraindicated in active peptic ulcers, severe renal/hepatic impairment, and heart failure. Devoid of anticholinergic side effects (safe in glaucoma and BPH).
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or analgesic treatment guidance. Always consult a registered physician or orthopedic specialist before taking pain relievers, anti-inflammatory medications, or anti-arthritic therapies.
Aceclofenac 100mg + Paracetamol 325mg Tablets
Paracetamol / Acetaminophen (Tablets 500mg, 650mg, 1000mg; Oral Suspension 120mg, 125mg, 250mg per 5ml; Drops 100mg/ml) is a first-line non-opioid analgesic and antipyretic on the WHO Model List of Essential Medicines. It selectively inhibits central prostaglandin synthesis through peroxidase-dependent inhibition of COX enzymes in the brain and spinal cord, activates descending serotonergic inhibitory pathways, and resets the hypothalamic thermoregulatory center to reduce fever through cutaneous vasodilation and sweating. Unlike NSAIDs, it does NOT inhibit peripheral cyclooxygenase, causing zero gastric mucosal ulceration, platelet dysfunction, or renal vasoconstriction. Indicated as first-line therapy for mild-to-moderate pain (headache, toothache, dysmenorrhea, osteoarthritis) and fever of diverse etiologies.
Aceclofenac Tablets 100 mg
Aceclofenac Tablets (100mg, 200mg Sustained Release) is an oral phenylacetic acid-derivative non-steroidal anti-inflammatory drug (NSAID) on the WHO Model List framework. It exhibits preferential inhibition of the COX-2 isoenzyme over COX-1, dramatically reducing synthesis of pro-inflammatory cytokines (IL-1beta, TNF-alpha) and PGE2, while stimulating synthesis of extracellular cartilage matrix components (glycosaminoglycans) in articular cartilage. Indicated for symptomatic relief of pain and inflammation in osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute musculoskeletal pain.
Aceclofenac 100mg + Paracetamol 325mg + Serratiopeptidase 15mg Tablets
Paracetamol / Acetaminophen (Tablets 500mg, 650mg, 1000mg; Oral Suspension 120mg, 125mg, 250mg per 5ml; Drops 100mg/ml) is a first-line non-opioid analgesic and antipyretic on the WHO Model List of Essential Medicines. It selectively inhibits central prostaglandin synthesis through peroxidase-dependent inhibition of COX enzymes in the brain and spinal cord, activates descending serotonergic inhibitory pathways, and resets the hypothalamic thermoregulatory center to reduce fever through cutaneous vasodilation and sweating. Unlike NSAIDs, it does NOT inhibit peripheral cyclooxygenase, causing zero gastric mucosal ulceration, platelet dysfunction, or renal vasoconstriction. Indicated as first-line therapy for mild-to-moderate pain (headache, toothache, dysmenorrhea, osteoarthritis) and fever of diverse etiologies.
Aceclofenac Sustained Release Tablets 200mg
Aceclofenac Tablets (100mg, 200mg Sustained Release) is an oral phenylacetic acid-derivative non-steroidal anti-inflammatory drug (NSAID) on the WHO Model List framework. It exhibits preferential inhibition of the COX-2 isoenzyme over COX-1, dramatically reducing synthesis of pro-inflammatory cytokines (IL-1beta, TNF-alpha) and PGE2, while stimulating synthesis of extracellular cartilage matrix components (glycosaminoglycans) in articular cartilage. Indicated for symptomatic relief of pain and inflammation in osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute musculoskeletal pain.